Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL

Saved in:
Bibliographic Details
Published in:Rare Cancers and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868757041275731968
collection WordPress RSS
FRELIP Feed Integration
container_title Rare Cancers and Therapy
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:94701
institution FRELIP
journal_source_facet Rare Cancers and Therapy
last_indexed 2026-06-23T03:33:13.061Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL
title_alt Resultados del mundo real entre beneficiarios de Medicare tratados con inhibidores de la tirosina quinasa de Bruton para LLC de novo
Résultats en vie réelle chez les bénéficiaires de Medicare traités par inhibiteurs de la tyrosine kinase de Bruton pour la LLC naïvement traitée
Desfechos do Mundo Real entre Beneficiários do Medicare Tratados com Inibidores da Tirosina Quinase de Bruton para LLC Virgem de Tratamento
title_auth Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL
title_es_txt Resultados del mundo real entre beneficiarios de Medicare tratados con inhibidores de la tirosina quinasa de Bruton para LLC de novo
title_fr_txt Résultats en vie réelle chez les bénéficiaires de Medicare traités par inhibiteurs de la tyrosine kinase de Bruton pour la LLC naïvement traitée
title_full Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL
title_fullStr Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL
title_full_unstemmed Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL
title_pt_txt Desfechos do Mundo Real entre Beneficiários do Medicare Tratados com Inibidores da Tirosina Quinase de Bruton para LLC Virgem de Tratamento
title_short Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL
title_sort real-world outcomes among medicare beneficiaries treated with bruton tyrosine kinase inhibitors for treatment-naïve cll
topic Oncology
General
Oncology
url https://link.springer.com/article/10.1007/s40487-026-00452-9